Form 4 for LH Labcorp
Accepted 2026-03-30 00:00:00 ET · period of report 2026-03-26 · accession 0000920148-26-000124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-30 | 2026-03-26 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $268.38 | -6,068 | 11.2K | -35% | -$1.63M |
| M | 2026-03-30 | 2026-03-26 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | A - Grant | $0.00 | +12.3K | 15.8K | +350% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-26 | F | D | 1,468 | $268.38 | 12,677.14 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-26 | A | A | 2,968 | $0.00 | 14,145.14 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-26 | F | D | 4,600 | $268.38 | 11,177.14 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-26 | A | A | 9,304 | $0.00 | 15,777.14 | D | — | — |